/Investor DB

NXTP — 2025 Investments

3 investments dated 2025 · listed companies and verified rows first · show all

CellRepcellrep.bioin𝕏Pre-Seed · May 2025 · $430K

CellRep develops an AI-powered platform that discovers small molecules to reprogram exhausted immune cells, enhancing their function for therapeutic applications including cancer immunotherapy and chronic viral infections.

AI & Machine LearningBiotechLongevity

Alfonso Amat(CEO & Co-Founder)inFederico Perdomo Celis(CSO & Co-Founder)inManuel Franco Cortés(CCO & Co-Founder)Julian Ganzabal(CAIO & Co-Founder)in

Co-investorsAIR CapitalGRIDXRiverwood Capital

Openlayeropenlayer.comin𝕏May 2025 · $14.5M

Openlayer provides a platform for testing, monitoring, and managing AI models across the development and production lifecycle.

AI & Machine LearningDeveloper ToolsEnterprise SoftwareSan Francisco, US

Gabriel Bayomi Kalejaiye(Founder)inVikas Nair(Co-founder & CPO)inRishab Ramanathan(Co-founder & CTO)inBoard Guillermo Rauch(Founder & CEO of Vercel)Gabriel Bayomi Tinoco Kalejaiye(Founder)inGabriel Bayomi(Co-founder & CEO)

Co-investorsGaingelsGround Up VenturesKPN VenturesMantis CapitalMento vcMindset Venture+11 more

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Surus AI

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.